Isoprenoid biosynthesis is an important area for anti-infective drug development. One isoprenoidt arget is (E)-1-hydroxy-2-methyl-but-2-enyl 4-diphosphate (HMBPP) reductase (IspH), which forms isopentenyl diphosphate and dimethylallyl diphosphate from HMBPP in a2 H + /2e À reduction. IspH contains a4FeÀ4S cluster,a nd in this work, we first investigated how small molecules bound to the cluster by using HYSCORE and NRVS spectroscopies. The results of these, as well as other structurala nd spectroscopic investigations,l ed to the conclusion that, in mostc ases, ligands bound to IspH 4FeÀ4S clusters by h 1 coordination, formingt etrahedral geometries at the unique fourth Fe, ligand side chains preventing furtherl igand (e.g.,H 2 O, O 2 )b inding. Based on thesei deas, we used in silico methods to find drug-like inhibitors that might occupy the HMBPP substrate binding pocket and bind to Fe, leadingt o the discovery of ab arbituric acida nalogue with a K i value of % 500 nm against Pseudomonas aeruginosa IspH.
Introduction
The enzymes IspG ((E)-1-hydroxy-2-methyl-but-2-enyl 4-diphosphate synthase, also known as GcpE) and IspH ((E)-1-hydroxy-2-methyl-but-2-enyl 4-diphosphate reductase, also known as LytB) are the last two enzymesoft he 2-C-methyl-d-erythritol 4-phosphate (MEP) pathway of isoprenoid biosynthesis in many bacteria,a sw ell as in some protozoa and in plants. [1] They are both 4FeÀ4S cluster-containing proteins that are involved in 2H + /2e À reductions:I spG converts 2-C-methyl-d-erythritol-2,4-cyclo-diphosphate( MEcPP, 1,S cheme 1) to (E)-1-hydroxy-2-methyl-but-2-enyl 4-diphosphate (HMBPP; 2), and IspH converts 2 to dimethylallyl diphosphate (3)a nd isopentenyl diphosphate (4), the building blocks of isoprenoid biosynthesis. Neithere nzymei sp roduced by humans( who use the mevalonate pathway for isoprenoid biosynthesis),b ut both are essential in plants and in many bacteria and protozoa, so IspG and IspH are of interest as potential herbicide or drug targets.I n earlierw ork, [2] we reported the first structureo fa nI spH, from Aquifex aeolicus (PDB ID:3 DNF), finding that one Fe atom in the cluster was lost duringc rystallization, and similarr esults were reported for IspH from Escherichia coli (PDB ID:3 F7T). [3] However, using computational modeling to re-add the unique fourth Fe, together with computational docking of HMBPP substrate 1,w ew ere able to produce [1, 2] ligand-bound structures that were very similart ol ater 4FeÀ4S IspH/1 X-ray structures, [4, 5] and these structures led to detailed mechanism of action models [6] [7] [8] for IspH catalysis. In other early work, we discovered,b ased on previous reports that alkynes could bind to and be reduced by 4FeÀ4S clusters, [9, 10] that alkyne diphosphates such as propargyl diphosphate (5,PPP) were low-micromolar inhibitors of IspH (as well as of IspG, which also contains a4FeÀ4S cubane-like structure). [1] Plus, the 1-amino (6)a nd 1-thio (7)a nalogues of HMBPP were found to inhibit IspH with K i valueso f2 0-50 nm, [11, 12] and we [13] and others reported their Xray structures (PDB IDs:3 ZGL, 3ZGN), which are basically the same as those found with the HMBPP substrate, with N,S binding to the unique fourth Fe. We also reported [14] [15] indicated the presenceo fa5-or 6-coordinate fourth iron in ligand-free oxidized IspH, with three clusters and most likely three additional N/O ligandsb ound to the fourth Fe. More recently,F aus et al. [16] reported an uclear resonant vibrational spectroscopy (NRVS) investigation of oxidized IspH and suggested that the three noncluster ligandsw ere H 2 Om olecules (or presumably OH À ,o ramixtureo fb oth). This structurei ss urprisingly labile,l eading to loss of the fourth Fe under crystallization conditions. Ligand-free IspH is also very sensitivet oO 2 ,w hereas HMBPP and PPP,a sw ell as an enolateliganded species, are much less sensitivet oc luster degradation by O 2, [17] suggesting that the presence of relatively bulky ligand side chains might block the H 2 O/O 2 binding that leads to lability.F or example, in the PPP (5)s tructure (crystallized from oxidized IspH), there is as ingle H 2 O( or OH À )b ound to the fourth Fe, [14] whereas the acetylene group is % 3.6 from the Fe, acting perhaps as ab arriert ow ater and oxygen ligands.
In our electron paramagnetic resonance (EPR) spectroscopy work on reduced IspH-5,w ec oncluded (based in part on early observations of Fe 4 S 4 -acetylenei nteractions)t hat there could be p-bonding with the fourth Fe in the reduced cluster, but with oxidized IspH, S = 0, so the system is not accessible by EPR and it is not clear if there is any alkyne interaction with the cluster.W et hus used NRVS to investigate the IspH-5 system.I na ddition, we used hyperfine sublevel correlation spectroscopy (HYSCORE) to investigate how another small ligand,C N À ,m ight bind to reduced IspH, which is of interest because CN À can be involved in p/back-bonding with d-orbitals. The results of these experiments, together with an examination of numerous IspH and IspG structures,s uggested the importance of h 1 s-bonding of ligands to the fourth Fe, together with the presence of ab ulky side chain, for IspH inhibition. We therefore performed in silico screening of possible inhibitors,f inding interesting new drug-like leads that, we propose, bind in this manner.
Results and Discussion
We first investigated the interactions of IspH with alkyne diphosphate 5,a sw ell as with as mall molecule ligand,C N À ,t o see if there were anyi nteractions of the alkyne with the cluster and whether the anionic CN À species bound, because in principle, both might be involved in metal-ligand p-bonding/backbonding. Then, using information from these and other related studies, we usedi ns ilico screeningt oi dentify new,d rug-like inhibitor leads.
NRVS spectroscopy of the IspH-5 complex

NRVS provides
57 Fe-specific information on the partial vibrational density of states (PVDOS) for Fe-X vibrational modes in amolecule. [18] For systems containing 4FeÀ4S cubane-like clusters, such as IspH, there are typicallyf ourm ain NRVS features, as shown schematically in Figure 1A : [18] [19] [20] [21] clustert orsional modes occur at < 100 cm
À1
, d (S-Fe-X) bending modes at % 150 cm À1 , n (FeÀS) (cluster) stretching modes at % 280 cm À1 , and n (FeÀS ter )( terminal) stretchingm odes in the % 320-370 cm À1 range. Althought here are, of course,a dditional mixed modes,t hese NRVS spectralf eatures are presenti n most-if not all-species containing 4FeÀ4S,a sw ell as 4FeÀ 3S clusters. [18] [19] [20] [21] For example, the NRVS spectrum of oxidized Pyrococcus furiosus ferredoxin containing aD 14C mutation (which has four Cys ligands; Figure 1B ,b lack line), [20] is very similar to that seen with the model compound . [20] The same basic features are also seen in oxidized IspH with HMBPP (2), the amino analogue (6), or the thiol analogue (7)a sl igands, [16] in which O, N, or Sa re directly bonded to the fourth Fe. In sharp contrast, these features are all less obvious (or absent)i nt he NRVS spectrum of IspH in the absence of 2, 6, or 7.
[ 16] In the presence of NO, the 4FeÀ4S cluster in P. furiosus D14C ferredoxin [22] is converted to Roussin's black salt,
À ,a nd the same set of peaks (at % 150, 280, and 370 cm
)a ss een in the 4-Cys-liganded protein are present. However,t here are stronga dditional peaks at % 540 and 610 cm À1 (red line, Figure1B);t his suggests ac ontribution from Fe-N-O and/orN -Fe-N vibrational modes, duei np art to metal-ligand p-bonding. We thus investigatedt he NRVS spectra of the IspH-5 complex to see whether there might be any evidencef or an interaction between the alkyne group and the oxidized4 FeÀ4S cluster( FeÀCb onding) that we previously proposed to be important in the reduced protein.
We show in Figure1Ct he NRVS spectrum of EcIspH in the oxidizeds tate ([Fe 4 S 4 ] 2 + )b ound to 5 (red line). The spectrumi s very similar to that seen with HMBPP (2)a sw ell as with the amino (6)a nd thiol (7)a nalogues of HMBPP,b ound to IspH [16] , and the [Fe 4 S 4 Cl 4 ]
2À model compound, [16] consistentw ith each Fe being bound to three cluster sulfurs and as ingle fourth atom. We also found no spectralshifts when au niformly 13 C-labeled analogue of PPP (5)w as bound to the protein (blue line, Figure 1C ). These results are consistentw ith the presence of as ingle water molecule [14] binding to the fourth Fe-the tetrahedral geometry seen in the other IspH structuresw ith 2, 6, and 7 [16] -withn os ignificant bonding between the alkyne group andt he cluster.Acompilation of the NRVS spectra of all of the variously ligated protein and model compound 4FeÀ4S
cluster-containing systems discussed above, highlighting their similarities, is shown in Figure S1 in the Supporting Information. The spectra with 5 were also dissimilar to that observed with IspH containing three H 2 Om olecules bound to the fourth Fe, again consistentwith the lack of multiple (alkyne, water) interactions with the fourth Fe.
We next sought to see how other small molecules/ions might bind to the 4FeÀ4S cluster.A ttempts to bind CO were unsuccessful, as determined by UV/Vis and EPR spectroscopy. However, in previous work [23] we showedt hat CN À bound to reduced IspH, yielding an EPR spectrum characterized by g values of 2.08, 1.94, and 1.93 (with as mall shoulder at g = 2.05 [23] ), but the number of ligands, as well as their binding mode, were unknown. We thus collected HYSCORE spectra using [ 13 [24] we simulated hyperfinec oupling tensorso fA( Figure 2C .Interestingly,the g values observed [23] in the EPR spectrum of IspH·CN( g = 2.08, 1.94, 1.93) are virtually identical to those found (g = 2.09, 1.94, 1.93) for CN À bound to Shewanella oneidensis HydG (minusthe "dangler Fe" [25] involved in formation of the [Fe(CO) 2 CN] synthon in hydrogenase function). Moreover,t he HYSCORE spectrum of [ 13 CN]-SoHydG had a 13 Ci sotropic hyperfine coupling A iso = À2.7 MHz, similar to the A iso = À2.9 MHz in PfFd with bound 13 CN [26] and the A iso % 2.5 MHz we find here. Plus, the 15 NH YS-CORE result for [ 13 C 15 N] À bound to SoHydG [25] was extremely similar to that we observed with IspH. So, IspH and SoHydG (the 4FeÀ4S cluster), as well as the (wild-type) ferredoxin, all appearedt ob ind CN À to the fourth Fe, forming at etrahedral species. It should be noted, however,t hat CN À wasa ctually av ery poor IspH inhibitor (IC 50 > 1mm)a nd as noted by Suess et al., [25] CN À binds only weakly to other biological [26] as well as synthetic [27] 4FeÀ4S clusters,a nd cysteined isplaces CN À from HydG. [25] Ligand bindingtoI spH and IspG:C lues for inhibitor discovery?
Ta ken together,t he results shown above, together with other reported work, [1] show that there are severalw ays that ligands ,a sw ell as h 3 ,c oordination is possible, [1] these cases are rare;4 )When alkyne diphosphates bind to oxidized IspH, the main clusteri nteraction is with af ourth H 2 O( or OH À ), with the alkyne fragment blocking addition of furtherH 2 Om olecules;5 )The diphosphate moiety must contributei namajor way to IspH inhibition, because propargyl alcohol itself is av ery weak inhibitor (K i > 10 mm); 6) These generalp atterns of ligand binding are very similari n IspH and in IspG. This is shown in Figure 3A ,i nw hich we compared PPP( 5)b inding to IspH and IspG. In both cases,t here is af ourth H 2 Ob ound to the unique, fourth Fe (d Fe-O = 1.9 ), whereas the alkynei sm ore distant (d % 3.6 ). The IspH-5 structure is very similar to the structures found with the amino (6)a nd thiol (7)H MBPP analogues, with the IspH-5 water molecule in the same position as the 6 and 7 NH 2 and SH groups, respectively,a nd the diphosphateg roupso ft hese structures also overlap (Figure3B). The IspH-5 water colocates with the ligand-bound oxygen in the IspG-MEcPP (1)1 st reaction intermediate [28] (Figure 3C ), and the IspG-5-bound water is in the same position as ac arboxylate oxygen in Glu307 in IspG (Figure 3D) . So, in the vast majority of cases, the fourth Fe has at etrahedral coordination geometry with O, N, or Sb inding to Fe. Unfortunately,t hese potent diphosphate-containing inhibitors are not activei nc ells, presumably because the diphosphate groups are very highly charged, reducing cell penetration. These observations led us to try and find more lipophilic, drug-like species that might bind to Fe, while also occupying the relatively large substrate-binding pocket.
Therefore, we next used an in silico approacht os creen al ibrary of drug-like compounds from the ZINC and NCI libraries, againstb oth Aquifex aeolicus IspH (PDB ID:3 DNF) and E. coli IspH (PDB ID:3 F7T). In both cases, the fourth Fe was reconstituted computationally as described previously, [2] and we used Glide docking, [29] again as described previously. [30] Using this approach, we obtained and tested 15 potential hits ( Figure S2 ) that were commerciallya vailable, for IspH inhibition. Fourteen out of the 15 compounds were inactive (IC 50 > 1mm), but compound 8 was active. We then obtained 11 commercially available analogues of 8 ( Figure S3 ) and tested them against E. coli IspH and Pseudomonas aeruginosa IspH, both organisms (unlike A. aeolicus)b eing important pathogens. The most active compounds were 8 and 9,w ith 8 having a K i value of 500 nm against P. aeruginosa IspH (Figure 4A ), and benzyl ana- www.chembiochem.org logue 9 having a K i value of 3 mm against E. coli IspH (Figure 4B) . AaIspHw as also inhibited by 9,w ith a K i value of 700 nm.T hese compounds are barbituric acid analogues that have some structural similarity to anti-infectives developedb y Pharmacia [31] and are predicted to bind to the fourth Fe of the 4FeÀ4S cluster.Aview of the AaIspH-9 complex (obtained by docking) from the electron-transfer side of the protein is shown in Figure 4C ,ab ottomv iew (substrate side) in Figure 4D ,a nd as ide view in Figure 4E .Aclose-up view of the ligand interacting with the fourth Fe in the cluster (d Fe-N = 2.6 ; d Fe-O = 2.7 )i ss hown in Figure 4F .T he ligand can clearly occupy the large substrate-binding site seen in the early X-ray structures, with the enolate form of the barbiturate reacting with the Fe, similar to the binding of related barbiturate enolates to Zn 2 + in other metalloproteins. [32, 33] Interestingly,w ew ereu nable to obtain an EPR spectrum of 9 bound to IspH (from the pathogen P. aeruginosa), with ligand addition resulting in loss of signali ntensity (Figure 4G ), due perhaps to as hift in redox potentialu pon ligand binding or ac hange in relaxation behavior.I ne ither case, 8 and 9 represent interesting new IspH inhibitor leads for further development, as they are far more lipophilic than diphosphates, they do not violateL ipinski's rules, [34] andt hey are not PAINS compounds. [ 
35]
Conclusion
The results shown above are of interestf or an umber of reasons. First, we found that NRVS spectra of the alkyne diphosphate inhibitor 5 bound to oxidized IspH werev ery similar to those found for binding of HMBPP (2), as well as those for the amino and thiol analogueso fH MBPP (6 and 7,r espectively). There was no evidence for any alkyne-cluster interaction. Second, we showed (using HYSCORE) that CN À bound to IspH (but was av ery weak inhibitor), and that the EPR/HYSCORE spectra of the CN À -bound protein werev ery similart ot hose found with CN À binding to SoHydG and P. furiosus ferredoxin, consistentw ith binding of as ingle cyanidei na ll three cases. Third, when compared with all knownI spH and IspG structures, it was clear that in most cases, O-, N-, andS -bonding ligands bound to the unique fourth Fe in the cluster, forming tetrahedral geometries.F ourth,b ased on the results noted above,w es oughtt of ind novel IspH inhibitors that might bind to Fe in the active site that were also more drug-like than the diphosphate inhibitors. Using in silico screening, we found that barbiturate analogues 8 and 9 had K i values of % 0.5-3 mm, with the barbiturate enolatem oiety binding, we propose, to the fourth Fe, with the hydrophobic domains occupying the substrate-binding site.
Experimental Section Chemical synthesis
General methods: Compound 8 and its analogues were purchased from Vitas-M Laboratory (Hong Kong) and used without further purification. Compounds were analyzed by LC/MS and were > 97 % pure. Other compounds were procured from Sigma-Aldrich, Asinex, Enamine, the National Cancer Institute (NCI) Developmental Therapeutics Program Open Chemical Repository (dtp.cancer.gov/), or TimTec. All chemicals for the resynthesis of 9 were purchased from Sigma-Aldrich. 1 HNMR spectra were obtained on Varian Unity spectrometers at 400 and 500 MHz. High-resolution MS and elemental analyses were carried out in the University of Illinois Mass Spectrometry and Microanalytical Laboratories. (9):T he synthesis of 9 was based on the synthesis of am orpholine analogue [36] and is illustrated in Scheme 2. Piperazine (59 mmol, 5.09 g) was dissolved in THF (26 mL) by heating. Benzyl bromide (8.4 mmol, 1mL) was added dropwise to as olution of piperazine in THF under reflux. After being stirred overnight under reflux, the reaction mixture was cooled to room temperature, and the THF was removed by evaporation. The resulting residue was washed with aq. K 2 CO 3 (20 mL), extracted with EtOAc (3 10 mL), washed with sat. NaCl (10 mL), dried with Na 2 SO 4 ,a nd evaporated to dryness under vacuum to yield 9a (1.29 g, 87 %yield).
Compound 9a (207 mg, 1.174 mmol) was dissolved in MeCN (3 mL) and Et 3 N( 1mL). Then, 2-fluoro-5-nitrobenzaldehyde (200 mg, 1.18 mmol) was added, and the solution was stirred at reflux overnight. The reaction mixture was then diluted with EtOAc (10 mL) and washed with water (10 mL). The aqueous layer was extracted with EtOAc (2 10 mL) and dried with Na 2 SO 4 ,t hen the solvent was removed under vacuum. The crude mixture was purified by column chromatography (hexanes/EtOAc, 2:1) to yield 9b (272 mg, 71 %yield).
Compound 9b (192.77 mg, 0.592 mmol) was dissolved in MeOH (10 mL). Barbituric acid (79.76 mg, 0.623 mmol) was added to this solution, and the mixture was heated to reflux and stirred overnight. The crude reaction mixture was loaded onto ac olumn and purified with (EtOAc/toluene, 2:3) to yield 9c (77.33 mg, 30 % yield).
Compound 9c (30 mg, 0.069 mmol) was dissolved in 8mLA cOH, and Zn dust (52 mg, 0.795 mmol) was added. The reaction mixture was stirred at room temperature for 2h and then quenched with www.chembiochem.org K 2 CO 3 (20 mL). Next, the mixture was diluted with EtOAc (20 mL), washed with aq. K 2 CO 3 (20 mL) and sat. NaCl (20 mL), dried with Na 2 SO 4, and the solvent was removed under vacuum. The crude mixture was purified by preparative TLC (100 %E tOAc) to yield 9 as an orange powder (3.92 mg, 9% yield): ESI-HRMS:c alcd: 406.1879, found:4 06.1868 C 22 H 24 N 5 O 3 ;c ompound purity determined by HPLC (Phenomenex C6-Phenyl 110A, 100 2mm, 3 mm, 250 nm, t R = 1.5 min): 99.7 %.
Sample preparation:
57 Fe IspHs were prepared as described elsewhere. [5] Compound 5 was described previously. [23] For EPR spectroscopy,E cIspH and PaIspH in the oxidized state ([Fe 4 S 4 ] 2 + )a nd in the presence of a2 0-fold excess of 5 were concentrated to % 0.3 mm by using an Amicon Ultra centrifugal device (EMD Millipore Corporation), then glycerol was added to 20 %(v/v)asaglassing agent. NRVS EcIspH samples were loaded into aL ucite cuvette (internal dimensions = 10 2.5 1mm), then frozen in liquid nitrogen.
NRVS measurements: NRVS samples (6 mm EcIspH) were attached to ac ryogenic sample base connected to al iquid helium (LHe) cryostat maintained at 10 K. Spectra were recorded according to published procedures at 03-ID at the Advanced Photon Source (APS). [37] The photon flux was % 2.5 10 9 photons s À at 1.1 eV energy resolution. Delayed nuclear Fe Kf luorescence was recorded with as ingle 1cm 2 square avalanche photodiode. To tal data acquisition time was 19 h. Data reduction was performed by using the PHOENIX software package, [38] in which the observed raw NRVS spectra were calibrated (aligned) to the nuclear resonant peak, normalized to the I0, then summed and converted to the 57 Fe partial vibrational density of states (PVDOS). The spectral conversion was optimized when the observed Stokes/anti-Stokes imbalance matched the imbalance calculated with the entered temperature as av ariable. The real sample temperature obtained by using this procedure was % 60 K.
CW-EPR/ENDOR/HYSCORE spectroscopy: All continuous wave (CW)-EPR experiments were performed on aV arian E-line 122 Xband spectrometer with an Air Products helium cryostat. Typical data acquisition parameters were:m icrowave frequency = 9.05 GHz;f ield center = 3250 G; field sweep = 1000 G; modulation frequency = 100 kHz;m odulation amplitude = 5Gauss;t ime constant = 32 ms;t emperature = 8-20 K. HYSCORE spectra were obtained on aB ruker ElexSys E-580-10 FT-EPR EPR spectrometer equipped with an Oxford Instruments CF935 cryostat. HYSCORE used af our-pulse sequence p/2 mw -t-p/2 mw -t 1 -p mw -t 2 -p/2 mw -echo; p/2 mw = 16 ns and p mw = 32 ns, 128 points for both t 1 and t 2 ,e ach with 24 ns steps. Time-domain data were baseline-corrected by using at hird-order polynomial, then Hamming windowed, followed by zero-filling, 2D-Fourier transformation, and symmetrization. Parameters were typically:m icrowave frequency = 9.65-9.72 GHz, temperature = 8-15 K, microwave power attenuation = 6.5-9 dB.
Spectral simulations: HYSCORE spectra were simulated by using the EasySpin program. [24] In silico screening: In order to find new inhibitors, we carried out in silico screening of AaIspH and EcIspH using ZINC and National Cancer Institute (NCI) libraries and Glide docking, essentially as previously described. [30] 
